Fundraising September 15, 2024 – October 1, 2024 About fundraising

Atezolizumab plus bevacizumab versus sunitinib in patients...

  • Main
  • 2019 / 5
  • Atezolizumab plus bevacizumab versus sunitinib in patients...

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Rini, Brian I, Powles, Thomas, Atkins, Michael B, Escudier, Bernard, McDermott, David F, Suarez, Cristina, Bracarda, Sergio, Stadler, Walter M, Donskov, Frede, Lee, Jae Lyun, Hawkins, Robert, Ravaud,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(19)30723-8
Date:
May, 2019
File:
PDF, 646 KB
english, 2019
Conversion to is in progress
Conversion to is failed